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ABSTRACT
Cellular secretion has been extensively studied in physiology. It is the process whereby 
cellular products are released outside the cell for with the pancreatic secretion of digestive 
enzymes being the best example. The secretory vesicles are thought to move by cytoskeletal 
rearrangements in the cell to reach the plasma membrane. The goal of this research was to 
identify proteins that might contribute to cytoskeletal rearrangement and determine whether they 
assemble at zymogen granules during secretion. These protein integral components include 
extracellular signal-regulated protein kinase (ERK), Wiskott-Aldrich Syndrome protein (WASP), 
and cortactin. This research indeed confirmed the presence of all three protiens on the zymogen 
granule following stimulation with CCK (2nM). ERK became apparent on the zymogen granule 
during a time course after stimulation with 2nM CCK. The ERK phosphorylation at the 
zymogen granule was also shown to be dependent on protein kinase C (PKC) and phosphatidyl 
inositol 4,5 bisphosphate (PI3K). The presence of cortactin and WASP was observed on the 
zymogen granule and provides a potential role in the cytoskeletal rearrangement necessary to 
traffic the vesicles to the plasma membrane. It is proposed, through this research, that ERK 
phosphorylates cortactin at the zymogen granule. Cortactin will subsequently activate WASP, 
which then stimulates cytoskeletal rearrangements through the Arp2/3 complex. These changes 















la. Effect of Time on Levels of ERK After Stimulation
lb. NIH Imaging of ERK Levels After Simulation Over Time 
2a. Effect of GF109 Inhibition on ERK
2b. NIH Imaging of ERK Levels After GF109 Inhibition
3a. Effect of Wortmannin Inhibition on ERK
3b. NIH Imaging of ERK Levels After WORT Inhibition
4a. Effect of GF109 Inhibition on WASP
4b. NIH Imaging of GF109 Inhibition on WASP
5. Relative Amount of Cortactin in Pure Zymogen Granules
6. Proposed Model of ERK Interaction with Cortactin and WASP
INTRODUCTION
Human physiology is a very complicated yet masterfully organized system. All 
components, or organs, work in conjunction with one another to produce physiological 
responses. One key player of this unified process is the pancreas, functioning in a dual role as an 
endocrine and exocrine gland. The pancreas secretes numerous enzymes necessary for digestion 
(exocrine) and hormones to regulate glucose concentration and metabolism (endocrine). The 
gland itself is divided up into three sections and lies horizontally within the abdominal cavity. 
The head region of the organ is attached via connective tissue to the duodenum of the small 
intestine. The duodenum and the pancreas also associate by means of a common blood supply.
The functional units of the endocrine pancreas are the islets of Langerhans. Within the 
islets of Langerhans, there are different types of endocrine cells in the islets and include a , P, D, 
and PP cells which secrete glucagon, insulin, somatostatin, and pancreatic polypeptide, 
respectively. Blood flows into the pancreas via branching of the celiac and superior mesenteric 
arteries and exits the pancreas via the portal vein to the liver. The acini, and the ducts they 
envelope, are surrounded by distinctly separate capillary systems.
The exocrine pancreas exhibits grape-like clusters of acini, with each containing an 
intercalated duct responsible for draining the acinus and a terminal acinar portion. This being the 
smallest duct in the unit, it then converges into larger ducts until it reaches the main pancreatic 
duct. Pyramidal epithelial cells found within the acini are responsible for the synthesis of the 
digestive enzymes in pancreatic juice. The acini have a polarized structure. The nucleus is not 
found in the center of the cell, but rather at the base of the cell. In addition, mitochondria can be 
found throughout the cell, and the Golgi apparatus and zymogen granules are situated mostly in
the apical region. These granules contain the digestive enzymes that will be used to promote 
breakdown of macromolecules in the intestine.
The pancreatic juice itself is a mixture of contributions from both the duct cells and the 
acini cells. The digestive enzymes originate in the acini, as described above, and the duct cells 
produce a bicarbonate alkaline secretion. The purpose of this combination is to ultimately 
neutralize the chime that is arriving at the small intestine from the stomach during digestion. The 
digestive enzymes are contained in secretory vesicles that fuse with the apical membrane during 
exocytosis. These vesicles are known as zymogen granules and store a number of active and 
precursor enzymes. Proenzyme precursors include trypsinogen, chymotrypsinogen, 
procarboxypeptidase, proelastase, and prophospholipase A. Lipase, a-amylase, ribonuclease, 
and deoxyribonuclease are already in their active states when they are packaged in the zymogen 
granules. The fact that proteolytic enzymes are not fully active prevents the enzymes from 
digesting the pancreatic tissue itself. Upon fusion with the plasma membrane and release of 
enzymes into the pancreatic duct, the vesicle membranes are rapidly recycled. These precursor 
enzymes are activated once in the duodenum and jejunum components of the small intestine. 
Trypsinogen is converted into its activated form of trypsin in a reaction catalyzed by intestinal 
enterokinase. The activation of some initial tryspin initiates a positive feedback that can then 
catalyze the conversion of more trypsinogen into trypsin. In addition, its proteolytic behavior 
allows it to convert the other enzyme precursors into their active states. Once activated, the 
trypsin and chymotrypsin work to break down proteins, phospholipase A breaks down 
phospholipids, ribo- and deoxyribonucleases hydrolyzing RNA and DNA respectively, and 
amylase breaking down carbohydrates.
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The release of enzymes by the acinar cells is regulated by hormones and 
neurotransmitters. Hormones can include secretin and cholecystokinin (CCK), while
acetylcholine is a parasympathetic neurotransmitter promoting release. Secretin is responsible 
for triggering the release of the alkaline component of pancreatic juice, and CCK is responsible 
for stimulating the release of the enzymatic component. The regulatory mechanisms for these 
two events are the source of much scientific investigation. Sophisticated feedback control 
mechanisms regulate the release of these digestive enzymes into the intestine. Many of the 
secretion details have already been identified, but a great deal remains to be elucidated. The 
cascade of events that extends from stimulation to secretion was the subject of this investigation. 
More specifically, components within the secretory cascade (ERK and cortactin) were analyzed 
in detail to determine their significance and role in the process independently as well as in 
conjunction with one another.
CCK acts through a 7-transmembrane G protein-coupled receptor. Through this receptor, 
CCK is able to activate multiple signaling cascades and therefore regulate many cellular 
functions in the pancreas. The ligand bound CCK receptor activates a heterotrimeric G protein 
from the Gq family. Upon activation, the subunits dissociate, with the a-subunit then activating 
a phospholipase C-p (PLCp). PLCp then creates IP3 and diacylglcerol (DAG) by cleaving 
phosphatidylinositol 4,5-bisphosphate. Each component goes on to activate another member of 
the stimulation cascade. Once IP3 binds to its intracellular receptor, it triggers the release of 
intracellular calcium. DAG is necessary to activate protein kinase C (PKC) isoforms. Both 
Ca2+ and PKC work together to arbitrate the secretion of digestive enzymes via zymogen
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granules. CCK has also been shown to activate another Gq subunit (Gs) which ultimately leads 
to the increase in the amount of cAMP present (Dabrowski etal., 2002).
The transport of secretory vesicles to the plasma membrane takes place on actin filaments 
once the vesicles have been transferred from microtubules. Microtubules and actin filaments 
produce a directionality of movement by having + and -  ends to which the vesicles migrate. The 
+ barbed end of these filaments attach themselves to the plasma membrane; this serves as the 
highway for vesicle transport. Both actin filaments and myosin motors have been implicated in 
the exocytic vesicle transfer in secretory cells. The subapical actin filaments are likely 
responsible for regulating exocytosis of vesicle contents and the membrane retrieval that takes 
place after secretion (Doctor et al, 2002). Microtubules specifically appear to deal with the 
longer range transport, while actin acts as a local roadway for short distance moving. Arp 2/3, an 
actin associated protein, complex is responsible for severing the actin uncapped barbed ends of 
the actin filaments and creating new barbed ends. Once the Arp 2/3 complex is formed, it 
triggers new filament formation for branching networks, and intitates cortical actin 
polymerization that takes place during plasma membrane reorganization. Arp 2/3 also aids in the 
formation of the regulatory actin structures on vesicles. Actin nucleation promoting factors 
(NPFs) provide the stimulus for Arp 2/3 complex activation. WASp, N-WASp, and Scar/WAVE 
are all members of the WASP family proteins and are all powerful activators of the Arp 2/3 
complex (Daly, 2001).
Cdc42 and Rac are other proteins that initiate cortical cytoskeletal rearrangement via the 
activation of Arp 2/3. Cdc42 and Rac require assistance from the Wiskott-Aldrich Syndrome 
protein (WASp) superfamily in order to initiate cortical actin polymerization. N-WASp contains
a carboxyl-terminal motif that regulates binding to Arp 2/3 complex (Weed et al., 2000), while 
the WASp proteins serve as a target of Cdc42/Rac cortical-actin polymerization, triggering 
binding and activation of the Arp 2/3 complex via stimulation of actin nucleation activity 
(Parsons and Weed, 2001). A number of other actin binding proteins are recruited during 
cytoskeletal regulation, one of which being cortactin (p80/p85). Cortactin has been referenced in 
signaling mediated by multiple extracellular stimuli (Huang et al., 1997). Cortactin is a multi- 
domain structure that is expressed in almost all mammalian tissues.
The N-terminal section of cortactin binds to F-actin and initiates the activation of Arp2/3 
complex, ultimately leading to actin filament assembly (Welch et al., 1998). This N-terminus 
also targets cortactin to the actin reassembly near the membrane. Using negative staining and 
electron microscopy, it was found that most F-actin strands became thicker and formed bundle­
like structures in the presence of cortactin and only single strands in cortactin’s absence, 
suggesting an influential role (Huang et al., 1997). The C-terminus SH3 domain interacts with 
the regulators of the actin reassembly components such as dynamin, WASP interacting protein 
(WIP), and N-WASP (Kinley et al., 2003). Cortactin has also been shown to have the ability to 
activate Arp2/3 alone. Even though cortactin acting alone elicits a weaker response than going 
through N-WASP, it does show that cortactin can have a direct effect on Arp 2/3 (Weaver et al., 
2001). N-WASP activates the Arp 2/3 complex by a transient interaction that increases the 
association of the Arp 2/3 with an existing actin filament; the N-WASP can then be released 
from the complex by replacement with cortactin. The high affinity of cortactin for the activated 
Arp 2/3 complex is needed to release WASP from the branching site and increase stabilized 
nucleation sites for rapid actin filament growth (Uruno, 2003). Cortactin may bridge sites of
actin reorganization with signaling complexes and, in addition to recruiting other proteins that
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may regulate Arp 2/3 actin polymerization (Weed et al., 2000). Cortactin may also perhaps 
contribute in organizing transmembrane receptor networks, for example the tight junction 
complex (Weed and Parsons, 2001). Cortactin is also involved with a second type of cellular 
junction, the adherins junction, whose formation is vital in tissue organization of developing 
organisms (Yap et al., 1997).The results suggest that Arp 2/3 activation and actin network 
stabilization is a conserved cellular function of cortactin. Cortactin’s interaction with the 
scaffolding proteins and dynamin suggest a link between transmembrane receptor complexes and 
membrane vesicle dynamics to specific areas of active actin polymerization. Therefore, cortactin 
could act as a significant mediator for ligands to regulate the cytoskeletal reorganization.
Significantly, CCK stimulation of the pancreas is able to initiate a signaling cascade that
results in the phosphorylation of proteins in the ERK cascade. The ERK cascade transmits
signals from cell-surface receptors to specific downstream targets via phosphorylation. The two
terminal signaling components of this cascade are extracellular signal-regulated protein kinase
1(ERK 1) and ERK2. If this cascade were to be blocked, then growth-stimulating agents would
yield unsuccessful cell proliferation (Dabrowski etal., 1997). The CCK-induced ERK cascade
has been shown to stimulate the formation of a Shc-Grb2 complex, utilizing the tyrlosyl
phosphorylation of She. Daulhac etal.(1999) suggest that She is a Src substrate, and that Src is
activated by CCK. Once the Src-type tyrosine kinases are active, they then proceed to
phosphorylate precise tyrosine locations on the She protein. The activated She is now able to
form a complex with growth-factor-receptor-bound protein 2(Grb2). Grb2 has the role of pulling
a model Ras-guanyl nucleotide exchange factor, known as SOS, to the cellular membrane and
activating the molecule, utilizing its SH3 domain. SOS is a guanine nucleotide exchange factor
and will cause GTP to replace GDP on Ras. The function of activated Ras is to attach to Raf
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kinases with high affinity and cause the resultant migration to the cellular membrane, ultimately 
leading to the activation of Raf. Signaling by Ras has been associated with such processes as 
cell division, cell adhesion, differentiation, cell survival, and significanctly, cytoskeletal 
rearrangements (Chan et al., 1999). Raf kinases will phosphorylate and activate the downstream 
substrate MEK. There exists two MEK isoforms, both of which are able to activate another 
downstream substrate, ERK, via phosphorylation of a Thr-Glu-Tyr motif. MEK is a part of a 
unique class of dual-specificity kinases that have the ability to phosphorylate both threonine and 
tyrosine residues (Dhanasekaran and Premkumar, 1998). ERK is a serine/thronine kinase with 
over 50 different identified substrates. The range of substrates includes cytoskeletal proteins, 
other kinases, phosphatases, enzymes, and transcription factors. The substrate target and 
physiological response is a result of a cell-specific downstream substrate combination and 
subcellular compartmentalization (Garcia etal, 2002).
Substrate recognition by members of the ERK cascade is enhanced by their high binding 
affinity. Generally, the substrate proteins contain MAPK-docking sites. These sites are located 
a distance away from the phosphorylation site. These two sites, docking and phosphorylation, 
create a bipartite recognition strategy and leads to the discriminatory nature of ERK when 
choosing substrates. Eamples of an ERK substrate include the phosphorylation of STAT3, part 
of a group of cytoplasmic transcription factors that translocate to the nucleus after tyrosine 
phosphorylation at the plasma membrane (Chung et al., 1997). ERK1 and ERK2 can also form a 
stable complex with the microphthalmia-associated transcription factor (MITF), a tissue-specific 
MAPK substrate found in melanocytes. This particular substrate coordinates gene expression in 
such processes as stem cell maintenance, differentiation, melanogenesis and cell survival 
(Goding, 2000).
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An important study (Campbell et al.,1999) determined that EGF (epidermal growth 
factor)-induced activation of the Ras-Raf-MEK-ERK pathway is responsible for the cortactin 
serine and threonine phosphorylation. A study that inhibited the MEK component of the cascade 
found that the cortactin activation still took place, implying that the true regulator had to be 
somewhere downstream of MEK. Upon reviewing peptide mapping data, ERK lA has been 
implicated as the protein responsible for phosphorylating cortactin at serine-405 and serine-418 
ERK consensus sites within the proline-rich domain. Because these sites are located in the SH3 
binding sites, one proposed theory is that ERK-mediated serine phosphorylation may regulate an 
intermolecular interaction between the cortactin SH3 domain and sequences within the proline- 
rich domain. This would then allow the SH3 domain to bind with other ligands. Other 
serine/thronine kinases may also play a role in the phosphorylation of cortactin based on the 
number of kinases activated by MEK.
In cells that are considered cortactin over-expressing, there is a sustained ERK 
activation. The potentiating of ERK signaling in these cells may provide further evidence for 
cortactin’s role in cell migration since cortactin phosphorylation by ERK has been shown in 
recent studies to increase the capacity of cortactin to boost N-WASP-mediated actin 
polymerization (Martinez-Quiles et al., 2004).
Cytoskeletal reorganization is an important feature in both processes of exocytosis and 
endocytosis. Cortacin has also been shown to associate with the regulators of endocytic vesicle 
fission. In addition, the partnership with Arp 2/3 works with endosomal vesicles as well, 
solidifying the possibility of cortacitn’s actin nucleation activity (Timpson et al., 2005).
Cortactin couples Arp2/3 complex-mediated actin dynamics to endocytosis and vesicle
movement by binding to dynamin 2. The cortactin-dynamin 2 complex can, therefore, regulate 
the organization of actin filaments associated with membranes.
It has been previously determined that cortactin regulates membrane associated actin 
filaments, with WASP aiding in the initiation of cortical actin polymerization. ERK has also 
been shown responsible for cortactin serine and threonine phosphorylation. If these components 
are vital to the process of cellular secretion, then those components should be present in the 
zymogen granule. This study confirms the fact that WASP, ERK, and cortactin are all present on 
the zymogen granule and that their increases during granule exocytosis. A model can then be 
formulated which incorporates these known components.
MATERIALS AND METHODS
w
Isolation of Pancreatic Acini
Pancreatic tissue was harvested from male Sprague-Dawley rats ranging from 125-190g. 
Light ether anaesthesia followed by cervical dislocation was used to euthanize the rat. The 
procedure was approved by the NIUIACUC committee (protocol #221). Dissection of the 
pancreas from the rat followed swiftly. Fat was removed from the pancreas, minced, and 
transferred to a 50ml culture tube containing 20ml of Ringer solution (Medium 199, including: 
10mMN-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid [HEPES], lmg/lml bovine serum 
albumin [BSA], trypsin protease inhibitor [.lmg/ml], and 0.1 mM phenyl methyl sulfonyl 
fluoride [PMSF]). A shaking water bath set at 37 degrees C was then used to incubate the tissue 
for 10 minutes. The cell suspension was given sufficient time to settle and the supernatant
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removed. Prior to experimental treatment, the pancreatic cells were washed and resuspended in 
20ml of Ringer.
Chemicals
All required reagents, antibodies, agonists, and inhibitors used during the course of this project 
were purchased from various biochemical companies in the United States. Protease inhibitors 
including phenyl methyl sulfonyl fluoride (PMF), (Sigma Chemical Company, St. Louis, MO), 
trypsin inhibitor (Gibco BRL, Inc.), and leupeptin were used as supplements to the incubation 
solution. Cholecystokinin, a known physiological agonist for pancreatic secretion, was 
purchased from Calbiochem-Novabiochem Corp. LaJolla, CA.
Primary antibodies including polyclonal rabbit anti-ERKl IgG, polyclonal rabbit anti- 
ERK2 IgG, and polyclonal rabbit anti-WASP and anti-Cortactin were purchased from Santa 
Cruz Biotechnology, Inc. Horseradish preroxidase, labeled anti-rabbit IgG secondary antibody 
was also purchased from Santa Cruz Biotechnology, Inc.
Protein Assay
Protein assays were conducted using the Bio-Rad Bradford Protein Assay Kit with bovine 
serum albumin as a standard. Protein fractions were incubated in 4 ml of a 1:4 dilution of 
protein dye stock solution for 15 minutes at room temperature. Absorbencies were measured 
with a Beckman DU-60 sepectrophotometer at a wavelength of 595nm.
Amylase Assay
Amylase assays were performed by a modified version of Bemfeld (1955), in order to 
determine the extent of secretion from the pancreatic acini during treatment. The disaccharide 
standard used in this study was maltose. Samples of 25 pi were incubated with 75pl of amylase 
resuspension buffer (0.2% Trito X-100, 50 mM Tris, 100 mM NaCl, and 10 mM CaC12) and 100 
pi substrate (1% amylopectin, 40 mM MOPS, 60 mM NaCl) at 37 degrees C for 30 minutes in a 
shaking water bath. The reaction was halted with the addition of 0.2 ml stop-development 
reagent (1% 3,5 dinitrosalicyclic acid, 0.4 N NaOH, 1.06 M sodium potassium tartarate). The 
resulting fractions were then heated din a dry bath for 7 minutes at 95 degrees C. The fractions 
were cooled and diluted with the addition of 2.6 ml of water. Individual absorbencies were read 
with a Beckman DU-60 spectrophotometer at a wavelength of 530 nm. Amylase release was 
 ^ then plotted as a function of time.
Electrophoresis and Electroblotting
Frozen samples, previously solubilized in laemmli buffer, were heated at 95 degrees C 
for 10 minutes after removal from -80 degree C storage. After cooling, equal amounts of each 
sample were then loaded into a discontinuous SDS-polyacrylamide gel (gel composition of 4% 
acrylamide/bis-acrylamide in the stacking gel and 12% acrylamide/ bis-acrylamide in the 
separating gel). The samples were electrophoresed at 100V for 60-90, or until the bromophenol 
blue dye front had reached approximately 1-2 mm from the bottom of the gel. After 
electrophoresis, gels and nitrocellulose sheets were equilibrated for 10 minutes in transfer 
electrode buffer (192mM glycine, 20mM Tris, 20% methanol) with the purpose of removing 
extraneous salts and detergents from the gel and to uniformly wet the nitrocellulose film.
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Proteins were then electroblotted onto a pure nitrocellulose membrane for 1 hour at 100V at 4 
degrees C. The electroblot was performed using the Mini-Trans electroblotting apparatus (Bio- 
Rad Laboratories).
Western Blotting and Enhanced Chemiluminescence (ECL)
After the elctroblotting process, unoccupied reactive sites on the nitrocellulose sheet were 
blocked by rocking with 10% nonfat dry milk in TTBS (250mM NaCl, 20mM Tris [pH 7.5] 
0.05% Twen-20) for 90 minutes at room temperature. Following blocking, nitrocellulose blots 
were washed 6 times with a TTBS solution on a rocker at room temperature for 5 minute 
intervals. After washing the nitrocellulose blots were then incubated on a rocker overnight at 4 
degrees C or for one hour at room temperature in a solution of 1% non-fat dry milk in specific 
salt concentration TBS and a primary antibody. A 1:1000 dilution was used for stock polyclonal 
rabbit primary antibodies. The blots were then washed six times on 5 minute intervals with 
TTBS at room temperature on a rocker.
Primary antibody binding to proteins was detected using a 1:2000 dilution of stock 
horseradish peroxidase labled anti-rabbit IgG. The blot was then incubated with the secondary 
antibody in 1% nonfat dry milk in TTBS for one hour at room temperature on a rocking 
platform. Following the incubation with the secondary antibody, the blots were again washed six 
times on 5 minute intervals with TTBS on the rocker. After the final wash, the bolts were then 
exposed immediately to lumnol developer solution (equal volumes of cyclic diacylthydrazide 
luminal and alkaline enhancer). This method relied upon the ability of bound horseradish 
peroxidase to oxidize the luminal and thereby excite the cyclic diacylhydrazide to a higher 
energy state. Once excited, the activated compound decays to a lower energy state and emits a
photon of light (wavelentght max = 428nm) in the process. The chemiluminescence was 
detected using blue light-sensitive autoradiographic ECL Hyperfilm in a darkroom. This 
exposure was performed in a standard film-holding cassette for 15 seconds to 30 minutes, 
depending on the antibody used and the amount of the starting samples. The exposed Hyperfilm 
was then developed and fixed in an automated film developer.
Image Scanning and Quantification
Following the western blotting procedure and enhanced chemiluminescense, protein bands on 
the ECL film were acquired using the computer program Adobe Photoshop 5.0. These 
scannedprotein bands were then quantified using the NIH Image 1.61 computer program.
RESULTS
CCK is a hormone that is known to induce the release of preformed secretory vesicles 
containing pancreatic enzymes (Yoshida et al., 1997). One of the signaling pathways thought to 
be involved is the ERK kinase system based on its reported ability to phosphorylate cortactin. 
This contention was verified experimentally when isolated pancreatic acinar cells were treated 
with 2nM CCK. Firgure 1 shows that, over time, acinar cells stimulated with CCK (2nM) 
exhibited significant increase in ERK phosphorylation, with the first apparent signs on zymogen 
granules at 10 minutes. The most dramatic increase becomes clear between the 15 minute and 
20 minute time course, with about a 3 fold increase. This confirms the presence of ERK on the 
zymogen granule, and further confirms the fact that ERK is being phosphorylated a short time 
after stimulation of the cell has occurred.
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Figure 1. a) The effect of time on levels of ERK on zymogen granules following stimulation 
with CCK (2nM).
b) NIH imaging and quantification of Western Blot results show a significant increase in the 
percent of tyrosyl phosphorylation of ERK as time goes on, with the most notable increase 
between K15 and K20.
14
ERK phosphorylation was minimally detected in those isolated cells that remained 
unstimulated, as well as showed a significant decrease in phosphorylation when stimulation was 
inhibited. Figure 2 shows that the increase in ERK phosphorylation was dependent on protein 
kinase C (PKC). CCK stimulates tyrosyl phosphorylation of She and the formation of Sch- 
Grb2 complex through a PKC-dependent mechanisim (Dabrowski et ah, 1997). GF109 blocks 
PKC activity and the figure shows that ERK phosphorylation decreases when the cells were 
treated with the inhibitor prior to stimulation with CCK. This implies that PKC must be 
activated in order to have substantial phosphorylation of ERK on the zymogen granules. The 
CCK stimulated cells exhibited twice the level of ERK phosphorylation compared to the GF109 
treated cells, though both were significantly higher than that of the uninhibited control. It was 
postulated that the CCK receptor leads to activation of the ERK kinase cascade by protein kinase 
C phosphorylation of Raf (Williams et al., 2002).
42 KD
CON CCK GF109
Figure 2. a) The effect of GF109 inhibition on ERK. CON represents the degree of 
phosphorylation in untreated pancreatic acinar cells (PAC’s). CCK rpepresents the degree of 
phosphorylation in cells treated with CCK (2nM) for 5 minutes. GF109 represents the degree of 
phosphorylation in cells pre-treated with GF109 for 10 minutes prior to the addition of CCK 
(2nM) for 5 minutes.
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b) NIH imaging and quantification of Western Blot results show CCK caused a significant 
increase in the percent of tyrosyl phosphorylation of ERK. GF109, a PKC-inhibitor, 
demonstrated inhibition of tyrosyl phosphorylation of ERK.
The increased phosphorylation of ERK as a result of CCK (2nM) stimulation is also 
shown to be dependent on phosphorylation of phosphatidyl inositol 4,5 bisphosphate (Figure 3). 
The enzyme, phosphatidylinositol3-kinase, creates lipid binding sites that can recruit proteins to 
the membrane. Inhibition of PI 3-Kinase activity by Wortmannin, a specific inhibitor, has been 
shown to block growth factor-induced cell proliferation (Daulhac et al., 1999). Figure 3 shows 
that Wortmannin can also block the tyrosyl phosphorylation of ERK on zymogen grandules, 
suggesting that the recruitment of these proteins to the membrane surface is a requirement. The 
difference in phosphorylation between PI3K inhibited and uninhibited samples was about seven 
fold. This suggests that a wortmannin-sensitive PI 3-kinase is an independent protein recruiting 
aspect of zymogen granule activation. Without these lipid signals, apparently the appropriate 
protein complexes do not form on the surface of the zymogen granule membrane.
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WORT CON CCK
Figure 3. a) The effect of Wortmannin inhibition on ERK. CON represents the degree of 
phosphorylation in untreated pancreatic acinar cells (PAC’s). CCK represents the degree of 
phosphorylation in cells treated with CCK (2nM) for 5 minutes. WORT represents the degree of 
phosphorylation in cells pre-treated with WART for 10 minutes prior to addition of CCK (2nM) 
for 5 minutes.
b) NIH imaging and quantification of Western Blot results show CCK caused significant 
increase in the percent of tyrosyl phosphorylation of ERK. WART inhibited tyrosyl 
phosphorylation of ERK.
17
WASP, a protein known to participate in the reorganization of actin micorofilaments was 
also shown to be present on zymogen granules (Figure 4). Figure 4 shows that, like ERK, the 
level of WASP increases on zymogen granules when cells are stimulated with CCK (2nM). 
When cells were treated with the PKC-inhibitor GF109, there was a dramatic decrease in the 
amount of WASP present. This implies that PKC stimulation by the pancreatic acinar cells is 
necessary to amplify the amount of WASP at zymogen granules leading to enzymatic secretion.
CON CCK GF109
60 KD
Figure 4. a) The effect of GF109 inhibition on WASP. CON represents the degree of 
phosphorylaytion in untreated pancreatic acinar cels (PAC’s). CCK represents the degree of 
phosphorylation in cells treated with CCK (2nM) for 5 minutes. GF1Q9 represents the degree of 
phosphorylation in cells pre-treated with GF109 for 10 minutes prior to the addition of CCK 
(2nM) for 5 minutes.
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b) NIH imaging and quantification of Western Blot results show CCK caused an 
increase in the percent of tyrosyl phosphorylation of WASP. GF109 demonstrated significant 
inhibition of tyrosyl phosphorylation of WASP.
Cortactin is a known actin-binding protein; therefore, its presence in an acinar cell could 
correspond to a function in the rearrangement of the zymogen granule associated microfilaments. 
Figure 5 confirms the presence of cortactin on pure zymogen granules that have remained 
untreated. Cortactin is shown to bind to WASP and N-WASP, which then interacts with the 
cytoskeletal components within the cell. Cortactin-induced migration is then dependent upon the 
WASP family member N-WASP (Kowalski et al., 2004). Cortactin binding to and activation of 
the WASP family is promoted by Erk phosphorylation (Quiles et al., 2004). This sequence of 
events could lead to the cytoskeletal reorganization necessary to traffic the zymogen granules to 




Figure 5. Each lane represents the amount of cortactin in pure zymogen granule (ZG) from 
pancreatic acinar cells.
DISCUSSION
The process of secretion is a vital physiological process. Many components within the 
cascade of events leading to secretion have yet to be fully elucidated. The identification of the 
key proteins their function has been the subject of many investigations to gain a complete 
understanding of cellular secretion. This study has shown that ERIC, WASP, and cortactin are all 
vital components in this cascade.
It is known that zymogen granules get to the cellular membrane and release there 
contents outside the cell. How they physically move to the membrane still under investigation. 
The obvious hypothesis is that cytoskeletal reorganization takes place to physically move these 
granules from there position inside the cell to the cell membrane perifery. This study has shown 
that ERK, WASP, and cortactin all been reside or associate with the zymogen granule, and an 
increase in response to stimulation with CCK (2nM). This leads to the postulation that they 
assist in the cytoskeletal reorganization, movement of the zymogen granule, and the subsequent 
secretion process.
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CCK receptors lead to activation of the ERK kinase cascade by protein kinase C 
phosphorylation of Raf (Williams et al., 2002). Therefore the present research is supported by 
the fact that activation of ERK was limited in the presence the PKC inhibitor GF109. The 
general scheme of ERK activation involves a cascade of phosphorylation events intitiated by 
stmimulation of the Ras proto-oncogne, which in turn allosterically activates one or more Raf 
family kinases (Garcia et al., 2002), leading MEK and ERK activation. Protein recruitment has 
also been shown to be vital to the increase in tyrosyl phosphorylation of ERK. Many proteins 
bind to PI 3,4,5 trisphosphate, which then results in the recruitment to the membrane. Inhibition 
of PI3-kinase activity by specific inhibitors or antibodies results in blockage of growth factor- 
induced cell proliferation (Daulhac et al., 1999). The inhibition of PI3K by Wortmannin resulted 
in a decrease of ERK activity. ERK phosphorylation enhances the capacity of cortactin to 
activate the WASP family member N-WASP (Quiles et al., 2004), and is therefore necessary to 
the cascade of events.
Cortactin is a known actin-binding protein provides a potential function for cytoskeletal 
reorganization to promote the migration of zymogen granules to the cellular periphery. The 
presence of cortactin was confirmed on pure zymogen granules, as seen in figure 5. In previous 
study, cortactin was found to be a prominent substrate for Src-related protein-tyrosine kinases 
and a potent F-actin cross-linking protein (Huang et al., 1997). It is, therefore, proposed that the 
activation of cortactin by ERK and its association with cytoskeletal structural components are 
necessary and responsible for the trafficking of the zymogen granules to the cell periphery for 
enzymatic release. For example, cortactin binds the mechanochemical GTPase dymin 2, which 
regulates the fission of endocytic vesicles, and the combination of cortactin and the Arp2/3
complex colocalize and associate with the endosomal vesicles (Timpson et al., 2005).
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ERK and cortactin work together to help proliferate the secretion response in acinar cells. 
In a previous study, actin nucleation promoting factors, such as WASP, stimulate the activity of 
Arp2/3 (Daly, 2004). The role of the activated Arp2/3 in the complex is thought to trigger new 
filament formation that could be then used in as a trafficking highway for the zymogen granules 
to migrate to the cell perifery. The results of the present experiment confirm that WASP is 
present on zymogen granules in stimulated cells and is also affected by the presence of PKC, 
much like the presence of ERK. ERK is responsible for the activation of cortactin, and cortactin 
is subsequently directly responsible for the activation of WASP.
Once these components, and there suspected contributions, to secretion were identified, a
working model was developed to reflect all of these elements and how they could possibly
interact together. This model has been proposed in Figure 6. Stimulus first arrives to the plasma
membrane receptors via hormonal stimulation, initiating a phosphorylation cascade. This
cascade begins with the Src tyrosine kinase. Src is then able to phosphorylate and activate She.
The role of She is to cause the Grb2 and SOS to form a complex with one another. Once the
complex has been put into place, Ras is recruited and subsequently activated by GTP (see Figure
6). Ras activation then leads to the activation of Raf. It has also been found that CCK-induced
activation of PKC leads to the activation of Raf, which has been shown in this research by the
reduced levels of ERK phosphorylation when PKC is inhibited. Continuing the cascade (Figure
6), Raf then activates the MEK/ERK pathways. This study has proposed that once the ERK
cascade has been initiated, it can then participate in a cytoskeletal rearrangement cascade,
intitiated by the phosphorylation of cortactin by ERK. WASP is then activated by the amplified
cortactin, which interacts with PKC to stimulate Arp 2/3 (Figure 6). This key step in the cascade
is still not fully understood, but does prove an excellent future direction for the research. The
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next step would, therefore, be to determine by what mechanism the Arp2/3 and the cytoskeleton 
is able to pull or push the zymogen granule to the membrane for exocytosis.
All of these proteins have multiple phosphorylation sites and therefore the likelihood of a 
more sophisticated regulation mechanism is great. For example, the CCK stimulus which leads 
to ERK activity also activates the Gq G-protein which in turn leads to PLCp activity. This 
enzyme produces IP3 and DAG. The PKC activity, shown to be necessary for ERK and WASP 
(see figures 2 and 4), is another, largely unexplored, route in the control of exocytosis and 
secretion. The role of PKC in the regulation of cytoskeletal reorganization and zymogen 
trafficking is therefore viewed as important.
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